DK2841431T4 - Dihydrat af benzothiophenforbindelse og fremgangsmåde til fremstilling deraf - Google Patents

Dihydrat af benzothiophenforbindelse og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number: DK2841431T4
Authority: DK; Denmark
Prior art keywords: benzothiophen; manufacture; dihydrate; compound; compound dihydrate
Prior art date: 2012-04-23

Application number

DK13722129.7T

Other languages

English (en)

Other versions

DK2841431T3 (da

Inventor

Hiroshi Yamashita

Tetsuya Sato

Takuya Minowa

Yusuke Hoshika

Hidekazu Toyofuku

Tatsuya Yamaguchi

Masahiro Sota

Shuuji Kawano

Takayuki Nakamura

Ryohei Eto

Takuma Ikebuchi

Kei Moriyama

Nobuaki Ito

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-23

Filing date

2013-04-23

Publication date

2024-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48428584&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2841431(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-04-23 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2017-03-06 Application granted granted Critical

2017-03-06 Publication of DK2841431T3 publication Critical patent/DK2841431T3/da

2024-02-12 Publication of DK2841431T4 publication Critical patent/DK2841431T4/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Otolaryngology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)

DK13722129.7T 2012-04-23 2013-04-23 Dihydrat af benzothiophenforbindelse og fremgangsmåde til fremstilling deraf DK2841431T4 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261636920P	2012-04-23	2012-04-23
US201361791378P	2013-03-15	2013-03-15
PCT/JP2013/062681 WO2013162046A1 (en)	2012-04-23	2013-04-23	Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same

Publications (2)

Publication Number	Publication Date
DK2841431T3 DK2841431T3 (da)	2017-03-06
DK2841431T4 true DK2841431T4 (da)	2024-02-12

Family

ID=48428584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK13722129.7T DK2841431T4 (da)	2012-04-23	2013-04-23	Dihydrat af benzothiophenforbindelse og fremgangsmåde til fremstilling deraf

Country Status (37)

Country	Link
US (5)	US9499525B2 (da)
EP (1)	EP2841431B2 (da)
JP (1)	JP5952917B2 (da)
KR (1)	KR102160395B1 (da)
CN (1)	CN104254530B (da)
AR (1)	AR090774A1 (da)
AU (1)	AU2013253372B2 (da)
BR (1)	BR112014026424B1 (da)
CA (1)	CA2870000C (da)
CO (1)	CO7111315A2 (da)
CY (1)	CY1119103T1 (da)
DK (1)	DK2841431T4 (da)
EA (1)	EA026541B1 (da)
ES (1)	ES2617881T5 (da)
FI (1)	FI2841431T4 (da)
HK (1)	HK1203073A1 (da)
HR (1)	HRP20170242T4 (da)
HU (1)	HUE031997T2 (da)
IL (1)	IL235044B (da)
IN (1)	IN2014DN08867A (da)
JO (1)	JO3325B1 (da)
LT (1)	LT2841431T (da)
ME (1)	ME02619B (da)
MX (1)	MX361723B (da)
MY (1)	MY170220A (da)
NZ (1)	NZ630260A (da)
PH (1)	PH12014502324B1 (da)
PL (1)	PL2841431T5 (da)
PT (1)	PT2841431T (da)
RS (1)	RS55742B2 (da)
SG (1)	SG11201406790VA (da)
SI (1)	SI2841431T2 (da)
SM (1)	SMT201700130B (da)
TW (1)	TWI562991B (da)
UA (1)	UA117456C2 (da)
WO (1)	WO2013162046A1 (da)
ZA (1)	ZA201407477B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en) *	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
AR090775A1 (es) *	2012-04-23	2014-12-03	Otsuka Pharma Co Ltd	Preparado inyectable
TWI562991B (en) *	2012-04-23	2016-12-21	Otsuka Pharma Co Ltd	Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
JOP20210047A1 (ar) *	2012-10-25	2017-06-16	Otsuka Pharma Co Ltd	عامل وقائي و/أو علاجي للأعراض السلوكية والنفسية المصحوبة بمرض تنكسي عصبي أو الأعراض الإندفاعية المصحوبة بمرض ذهني، يحتوي على بريكسبيرازول أو ملحه
KR20160138301A (ko)	2014-04-22	2016-12-02	오쓰까 세이야꾸 가부시키가이샤	브렉스피프라졸과 날메펜의 병용제 및 물질-관련 장애의 치료를 위한 이의 용도
CN104447723A (zh) *	2014-11-28	2015-03-25	瑞阳制药有限公司	7-(4-(4-(苯并[b]噻吩基)-1-哌嗪基)丁氧基)-2(1H)-喹啉酮的制备方法
CN104829603A (zh) *	2015-05-19	2015-08-12	杭州新博思生物医药有限公司	A晶型依匹唑派盐酸盐及其制备方法
CN106883223B (zh) *	2015-12-16	2021-11-23	北京福元医药股份有限公司	一种Brexpiprazole盐酸盐的纯化方法
WO2017106641A1 (en)	2015-12-17	2017-06-22	Assia Chemical Industries Ltd.	Solid state forms of brexpiprazole
EP3397636B1 (en)	2015-12-28	2021-08-04	Honour (R&D)	Process for the preparation of quinoline-2(1h)-one derivatives
JP2019059672A (ja) *	2015-12-28	2019-04-18	大日本住友製薬株式会社	治療抵抗性うつ病等の治療薬
WO2017134038A1 (en)	2016-02-01	2017-08-10	Hexal Ag	Anhydrate-free polymorphically pure micronized crystalline brexpiprazole dihydrate for use in intramuscular injectable sustained release formulations
US20170320862A1 (en)	2016-05-03	2017-11-09	Cadila Healthcare Limited	Process for the preparation of brexpiprazole and intermediates thereof
CN107365305A (zh) *	2016-05-12	2017-11-21	上海奥博生物医药技术有限公司	一种依匹哌唑新晶型及其制备方法
WO2017208251A1 (en) *	2016-05-31	2017-12-07	Cipla Limited	A new stable polymorph of brexpiprazole and process for preparation thereof
CN106188023A (zh) *	2016-07-04	2016-12-07	山东川成医药股份有限公司	一种依匹唑派的精制方法
PL233778B1 (pl)	2016-07-19	2019-11-29	Adamed Spolka Z Ograniczona Odpowiedzialnoscia	Sposob wytwarzania brekspiprazolu oraz zastosowanie zwiazkow posrednich w sposobie wytwarzania brekspiprazolu
EP3500247B1 (en)	2016-08-16	2020-05-27	H e x a l Aktiengesellschaft	Immediate release tablet of a benzothiophene compound
EP3500249A1 (en)	2016-08-16	2019-06-26	Hexal Aktiengesellschaft	Pharmaceutical compositions of a benzothiophene compound
CN107936005A (zh) *	2016-10-13	2018-04-20	上海科胜药物研发有限公司	一种依匹哌唑新晶型ii及其制备方法
CN111233848A (zh) *	2016-12-14	2020-06-05	上海博志研新药物技术有限公司	一种依匹哌唑甲醇合物、晶型a、及其制备方法和应用
WO2018141886A1 (en)	2017-02-02	2018-08-09	Hexal Aktiengesellschaft	Crystalline brexpiprazole
EP3501506B1 (en)	2017-12-19	2019-10-09	Alfred E. Tiefenbacher (GmbH & Co. KG)	Pharmaceutical tablet composition comprising brexpiprazole
CN111440158A (zh) *	2020-03-24	2020-07-24	石药集团中奇制药技术（石家庄）有限公司	一种盐酸依匹哌唑新晶型及其制备方法
US11229644B1 (en) *	2020-12-31	2022-01-25	Lake O'hara Llc	Methods of treating psychiatric disorders in obese patients with brexpiprazole
WO2022176017A1 (ja) *	2021-02-16	2022-08-25	大塚製薬株式会社	非晶質体及び当該非晶質体を含む組成物
WO2023067664A1 (ja) *	2021-10-18	2023-04-27	大塚製薬株式会社	ベンゾチオフェン化合物の新規結晶形及びその製造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR033485A1 (es) *	2001-09-25	2003-12-26	Otsuka Pharma Co Ltd	Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
CA2543242C (en) †	2003-10-23	2015-04-14	Otsuka Pharmaceutical Co., Ltd.	Controlled release sterile freeze-dried aripiprazole formulation and injectable formulation thereof
WO2006030446A1 (en)	2004-09-13	2006-03-23	Matrix Laboratories Ltd	Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts
DE102005001989A1 (de) *	2005-01-15	2006-07-20	Bayer Healthcare Ag	Intravenöse Formulierungen von PDE-Inhibitoren
TWI320783B (en) *	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
JP4315393B2 (ja)	2005-04-14	2009-08-19	大塚製薬株式会社	複素環化合物
PE20090387A1 (es) *	2007-05-24	2009-04-28	Novartis Ag	Formulacion de pasireotida
WO2009055675A1 (en) *	2007-10-26	2009-04-30	Repligen Corporation	Methods of identifying histone deacetylase inhibitors useful for neurological disorders
CN104127367A (zh) *	2008-01-30	2014-11-05	诺华股份有限公司	包含奥曲肽和三种线形聚丙交酯-共-乙交酯聚合物的缓释制剂
NZ603076A (en) †	2010-08-24	2014-12-24	Otsuka Pharma Co Ltd	Suspension and cake composition containing carbostyril derivative and silicone oil and/or silicone oil derivative
JP2012232958A (ja) *	2011-05-09	2012-11-29	Otsuka Pharmaceut Co Ltd	注射製剤
CN103717587B (zh) *	2011-07-28	2016-02-10	大塚制药株式会社	制造苯并[b]噻吩化合物的方法
JO3227B1 (ar) *	2011-09-08	2018-03-08	Otsuka Pharma Co Ltd	مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان
JOP20200109A1 (ar) *	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
AR090775A1 (es)	2012-04-23	2014-12-03	Otsuka Pharma Co Ltd	Preparado inyectable
TWI562991B (en) *	2012-04-23	2016-12-21	Otsuka Pharma Co Ltd	Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same

2013
- 2013-04-19 TW TW102114005A patent/TWI562991B/zh active
- 2013-04-22 AR ARP130101319A patent/AR090774A1/es unknown
- 2013-04-23 SG SG11201406790VA patent/SG11201406790VA/en unknown
- 2013-04-23 KR KR1020147032745A patent/KR102160395B1/ko active IP Right Grant
- 2013-04-23 IN IN8867DEN2014 patent/IN2014DN08867A/en unknown
- 2013-04-23 EA EA201491933A patent/EA026541B1/ru not_active IP Right Cessation
- 2013-04-23 PT PT137221297T patent/PT2841431T/pt unknown
- 2013-04-23 DK DK13722129.7T patent/DK2841431T4/da active
- 2013-04-23 US US14/396,224 patent/US9499525B2/en active Active
- 2013-04-23 AU AU2013253372A patent/AU2013253372B2/en active Active
- 2013-04-23 CA CA2870000A patent/CA2870000C/en active Active
- 2013-04-23 HR HRP20170242TT patent/HRP20170242T4/hr unknown
- 2013-04-23 LT LTEP13722129.7T patent/LT2841431T/lt unknown
- 2013-04-23 EP EP13722129.7A patent/EP2841431B2/en active Active
- 2013-04-23 CN CN201380021622.6A patent/CN104254530B/zh active Active
- 2013-04-23 ES ES13722129T patent/ES2617881T5/es active Active
- 2013-04-23 MY MYPI2014703139A patent/MY170220A/en unknown
- 2013-04-23 BR BR112014026424-4A patent/BR112014026424B1/pt active IP Right Grant
- 2013-04-23 JP JP2014550214A patent/JP5952917B2/ja active Active
- 2013-04-23 JO JOP/2013/0114A patent/JO3325B1/ar active
- 2013-04-23 MX MX2014012527A patent/MX361723B/es active IP Right Grant
- 2013-04-23 WO PCT/JP2013/062681 patent/WO2013162046A1/en active Application Filing
- 2013-04-23 ME MEP-2017-56A patent/ME02619B/me unknown
- 2013-04-23 SI SI201330538T patent/SI2841431T2/sl unknown
- 2013-04-23 UA UAA201412555A patent/UA117456C2/uk unknown
- 2013-04-23 RS RS20170214A patent/RS55742B2/sr unknown
- 2013-04-23 FI FIEP13722129.7T patent/FI2841431T4/fi active
- 2013-04-23 NZ NZ630260A patent/NZ630260A/en unknown
- 2013-04-23 PL PL13722129.7T patent/PL2841431T5/pl unknown
- 2013-04-23 HU HUE13722129A patent/HUE031997T2/en unknown
2014
- 2014-10-07 IL IL235044A patent/IL235044B/en active IP Right Grant
- 2014-10-14 CO CO14226629A patent/CO7111315A2/es unknown
- 2014-10-15 ZA ZA2014/07477A patent/ZA201407477B/en unknown
- 2014-10-17 PH PH12014502324A patent/PH12014502324B1/en unknown
2015
- 2015-04-13 HK HK15103588.5A patent/HK1203073A1/xx unknown
2016
- 2016-10-14 US US15/294,644 patent/US10407415B2/en active Active
2017
- 2017-02-28 SM SM201700130T patent/SMT201700130B/it unknown
- 2017-03-07 CY CY20171100293T patent/CY1119103T1/el unknown
2019
- 2019-09-09 US US16/564,972 patent/US20200140424A1/en not_active Abandoned
2020
- 2020-08-04 US US16/985,177 patent/US20210115030A1/en not_active Abandoned
2022
- 2022-02-14 US US17/651,042 patent/US20230049327A1/en active Pending

Also Published As

Publication number	Publication date
LT2841431T (lt)	2017-03-27
CA2870000A1 (en)	2013-10-31
RS55742B2 (sr)	2024-04-30
US20150087655A1 (en)	2015-03-26
MX361723B (es)	2018-12-14
TWI562991B (en)	2016-12-21
SI2841431T1 (sl)	2017-03-31
PH12014502324A1 (en)	2015-01-12
HRP20170242T8 (hr)	2017-09-22
KR20150013189A (ko)	2015-02-04
PL2841431T5 (pl)	2024-07-15
AR090774A1 (es)	2014-12-03
CO7111315A2 (es)	2014-11-10
US9499525B2 (en)	2016-11-22
CN104254530B (zh)	2016-09-21
HK1203073A1 (en)	2015-10-16
US20230049327A1 (en)	2023-02-16
ME02619B (me)	2017-06-20
ES2617881T3 (es)	2017-06-20
DK2841431T3 (da)	2017-03-06
FI2841431T4 (fi)	2024-04-18
EP2841431A1 (en)	2015-03-04
US10407415B2 (en)	2019-09-10
SI2841431T2 (sl)	2024-03-29
AU2013253372B2 (en)	2016-12-08
MX2014012527A (es)	2015-03-19
US20210115030A1 (en)	2021-04-22
HRP20170242T1 (hr)	2017-04-07
PL2841431T3 (pl)	2017-06-30
PH12014502324B1 (en)	2015-01-12
AU2013253372A1 (en)	2014-10-30
UA117456C2 (uk)	2018-08-10
TW201348229A (zh)	2013-12-01
JP2015514677A (ja)	2015-05-21
BR112014026424A2 (pt)	2017-06-27
CN104254530A (zh)	2014-12-31
SMT201700130B (it)	2017-03-08
WO2013162046A1 (en)	2013-10-31
EP2841431B2 (en)	2024-01-24
EA026541B1 (ru)	2017-04-28
JO3325B1 (ar)	2019-03-13
ES2617881T5 (es)	2024-05-22
KR102160395B1 (ko)	2020-09-28
HRP20170242T4 (hr)	2024-03-01
EA201491933A1 (ru)	2015-03-31
IL235044A0 (en)	2014-12-31
MY170220A (en)	2019-07-10
BR112014026424B1 (pt)	2022-09-13
SG11201406790VA (en)	2014-11-27
NZ630260A (en)	2015-09-25
IL235044B (en)	2019-05-30
PT2841431T (pt)	2017-03-07
IN2014DN08867A (da)	2015-05-22
HUE031997T2 (en)	2017-08-28
RS55742B1 (sr)	2017-07-31
JP5952917B2 (ja)	2016-07-13
CY1119103T1 (el)	2018-02-14
US20170066752A1 (en)	2017-03-09
EP2841431B1 (en)	2017-01-04
US20200140424A1 (en)	2020-05-07
ZA201407477B (en)	2015-12-23
CA2870000C (en)	2021-02-16

Publication	Publication Date	Title
DK2841431T4 (da)	2024-02-12	Dihydrat af benzothiophenforbindelse og fremgangsmåde til fremstilling deraf
DK3016741T3 (da)	2020-07-27	Fremgangsmåde til fremstilling af zeolitter og zeotyper
DK2739293T3 (da)	2020-08-24	Fremgangsmåder og sammensætninger til frembringelse af vaccinavirus
DK2837629T3 (da)	2017-06-19	Fremgangsmåde til syntetisering af sapropterindihydrochlorid
DK2730878T3 (da)	2019-06-11	Pladestak og fremgangsmåde til fremstilling af en pladestak
DK2890780T3 (da)	2020-09-21	Fremgangsmåder og sammensætninger til behandling af en genetisk tilstand
DK3454346T3 (da)	2021-11-01	Anordning til cylotronfremstilling af technetium-99m
DK3210978T3 (da)	2023-10-30	Fremgangsmåde til fremstilling af acesulfamkalium
DK2758349T3 (da)	2020-03-02	Vanadiumbaserede frittematerialer og fremgangsmåder til fremstilling heraf
DK3077513T3 (da)	2023-10-23	Sammensætninger og fremgangsmåder til fremstilling af (r)-retikulin og udgangsstoffer deraf
DK2919589T3 (da)	2020-02-03	Geleret konfekturevare og fremgangsmåde til fremstilling af en sådan konfekturevare
DK2908661T3 (da)	2020-02-03	Mikroalgemelgranulater og fremgangsmåde til fremstilling deraf
DK2847799T3 (da)	2020-11-02	Tagsten, anordning af tagsten og fremgangsmåde til fremstilling af en tagsten
DK2836460T3 (da)	2022-10-10	Fremgangsmåde til fremstilling af graphen
DK2670591T4 (da)	2019-09-16	Strukturelement og fremgangsmåde til dets fremstilling
DK2911527T3 (da)	2019-07-01	Mikroalgemelgranulater og fremgangsmåde til fremstilling deraf
DK3150710T3 (da)	2022-06-20	Fremgangsmåde til fremstilling af homoserin-lacton og organisk syre fra mikroorganisme-afledt o-acyl-homoserin
DK2985275T3 (da)	2020-01-20	Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre
DK2811835T3 (da)	2021-01-18	Fremgangsmåde til fremstilling af bagværk
DK2834229T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af ccr3-inhibitorer
DK3175852T3 (da)	2019-05-27	Difluorlactamsammensætninger til EP4-medierede osteorelaterede sygdomme og tilstande
DK2809782T3 (da)	2017-11-20	Forbedret fremgangsmåde til fremstilling af makrokugler
DK2757878T3 (da)	2016-02-08	Fremgangsmåde til fremstilling og forbedring af hestesko
DK2992953T3 (da)	2021-07-26	Fremgangsmåde til fremstilling af en mikroindkapsling, mikroindkapsling og sammensætning
DK2808346T3 (da)	2019-05-20	Fremgangsmåde til fremstilling af tørret biocellulose